Category: News from Asia-pacific
Mylan-Biocon Bags FDA Nod for Biosimilar Drug ‘Fulphila’, Reduces Infection Risk in Cancer Patients
US FDA approved Fulphila (pegfilgrastim-jmdb) – a biosimilar to Neulasta for reducing the chances of infection in patients with non-myeloid (non-bone marrow) cancer during chemotherapy. It is the first pegfilgrastim biosimilar that is approved by the US FDA.
It’s not only about Nipah Virus in Kerala!!!
This disease is not new in India but has revisited for the third time after previously outbreaking in the two districts of West Bengal – Siliguri and Nadia in 2001 and 2007 respectively. High fatality rate (about 70 percent) and easy person-to-person transmission of the disease had already been established during its previous encounters but still, there is no vaccine for the prevention or cure of the disease and only supportive treatment is given for the disease-related complications including neurological and respiratory complications.
IIT Roorkee’s Innovative Bone Implant Technology Could Tap Emerging Orthopedic Market
Indian Institute of Technology Roorkee (IIT Roorkee) scientists have developed an improved orthopedic implant technology for sustained drug release. Currently, the technology is with the company, Biotech Consortium India Limited (BCIL) for transfer, for the commercialization of the technology.
First Drug to Treat Polycystic Kidney Disease Bags FDA Approval
First drug treatment- Jynarque (tolvaptan) to slow down the decline in kidney function in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD) received USFDA approval. The drug is developed by Japanese biopharma, Otsuka Pharma.
Delhi-Based Healthcare Fintech Startup Raises $1 M in Seed Funding Round
Delhi-based healthcare financing startup, LetsMD has raised $1 million a pre-series A funding round led by SRI Capital.
New Potential Immuno-Oncology Drug for Blood Cancer Received Orphan Drug Status
Chinese biotech, Maxinovel Pharma’s immuno-oncology drug candidate- MAX-40279 received Orphan Drug designation from the US FDA for the treatment of ...
First Japanese Company Shionogi Receives CARB-X Funding for New Antibiotics Development against Superbugs
KEY POINTS CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) founded by US government Agencies and Wellcome Trust, London funds companies to ...
AI-Based Software EyeArt™ in Smartphone Could Prevent Vision Loss in 90% Diabetic People
KEY POINTS One in five diabetic Indians is at risk of developing diabetic retinopathy, which can lead to blindness. Eyenuk’s ...
A Chinese Biotech Raises $90 M in Series A for CAR-T Cell Therapy Development
Shanghai-based biotech JW Therapeutics has raised $90 million in Series A funding round, led by Temasek, Sequoia Capital China, and ...
HDFC Backs MedGenome, Raises $40 Million in Series C Funding
DNA diagnostics firm, MedGenome has closed the Series C funding round at $40 million. The new investors HDFC Ltd, HDFC ...